Heart:肺动脉瓣置换术后的室性心律失常研究

2018-10-23 MedSci MedSci原创

有相当多一部分的室性心律不齐(VA)在经导管肺动脉瓣置换术(TC-PVR)或外科肺动脉瓣置换术(S-PVR)后患者中是缺乏评估的,本研究的目的旨在比较和评估接受TC-PVR或S-PVR治疗的先心病患者在VA表现上的差异。本研究纳入了2010-2016年UCLA医学中心的接受TC-PVR或S-PVR治疗的先心病患者,主要终点事件是非手术相关的室性心律失常。最终共纳入了302名患者(TC-PVR, n

有相当多一部分的室性心律不齐(VA)在经导管肺动脉瓣置换术(TC-PVR)或外科肺动脉瓣置换术(S-PVR)后患者中是缺乏评估的,本研究的目的旨在比较和评估接受TC-PVR或S-PVR治疗的先心病患者在VA表现上的差异。

本研究纳入了2010-2016年UCLA医学中心的接受TC-PVR或S-PVR治疗的先心病患者,主要终点事件是非手术相关的室性心律失常。最终共纳入了302名患者(TC-PVR, n=172 and S-PVR, n=130)。与S-PVR相比,TC-PVR患者在术后30天的VA发生率更低(HR 0.20, p=0.002),但中远期的发生风险相似。在倾向调整模型中,S-PVR、手术年龄和右室流出道是VA的独立预测因子。

研究结果显示,与外科肺动脉瓣置换术相比,经导管肺动脉瓣置换术的短期室性心律失常发生风险更小,但中远期无明显差异。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1742529, encodeId=27e11e425295d, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Sat Mar 02 13:42:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774462, encodeId=d6e41e7446217, content=<a href='/topic/show?id=5f958205400' target=_blank style='color:#2F92EE;'>#肺动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82054, encryptionId=5f958205400, topicName=肺动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a03c38545465, createdName=cathymary, createdTime=Mon Aug 19 22:42:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808558, encodeId=4bb1180855848, content=<a href='/topic/show?id=1a6e8205e39' target=_blank style='color:#2F92EE;'>#肺动脉瓣置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82057, encryptionId=1a6e8205e39, topicName=肺动脉瓣置换)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Tue Feb 19 11:42:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356966, encodeId=4f2a1356966ac, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562988, encodeId=b370156298819, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576645, encodeId=3bb615e6645b8, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
    2019-03-02 yxch48
  2. [GetPortalCommentsPageByObjectIdResponse(id=1742529, encodeId=27e11e425295d, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Sat Mar 02 13:42:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774462, encodeId=d6e41e7446217, content=<a href='/topic/show?id=5f958205400' target=_blank style='color:#2F92EE;'>#肺动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82054, encryptionId=5f958205400, topicName=肺动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a03c38545465, createdName=cathymary, createdTime=Mon Aug 19 22:42:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808558, encodeId=4bb1180855848, content=<a href='/topic/show?id=1a6e8205e39' target=_blank style='color:#2F92EE;'>#肺动脉瓣置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82057, encryptionId=1a6e8205e39, topicName=肺动脉瓣置换)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Tue Feb 19 11:42:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356966, encodeId=4f2a1356966ac, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562988, encodeId=b370156298819, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576645, encodeId=3bb615e6645b8, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1742529, encodeId=27e11e425295d, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Sat Mar 02 13:42:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774462, encodeId=d6e41e7446217, content=<a href='/topic/show?id=5f958205400' target=_blank style='color:#2F92EE;'>#肺动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82054, encryptionId=5f958205400, topicName=肺动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a03c38545465, createdName=cathymary, createdTime=Mon Aug 19 22:42:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808558, encodeId=4bb1180855848, content=<a href='/topic/show?id=1a6e8205e39' target=_blank style='color:#2F92EE;'>#肺动脉瓣置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82057, encryptionId=1a6e8205e39, topicName=肺动脉瓣置换)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Tue Feb 19 11:42:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356966, encodeId=4f2a1356966ac, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562988, encodeId=b370156298819, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576645, encodeId=3bb615e6645b8, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1742529, encodeId=27e11e425295d, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Sat Mar 02 13:42:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774462, encodeId=d6e41e7446217, content=<a href='/topic/show?id=5f958205400' target=_blank style='color:#2F92EE;'>#肺动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82054, encryptionId=5f958205400, topicName=肺动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a03c38545465, createdName=cathymary, createdTime=Mon Aug 19 22:42:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808558, encodeId=4bb1180855848, content=<a href='/topic/show?id=1a6e8205e39' target=_blank style='color:#2F92EE;'>#肺动脉瓣置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82057, encryptionId=1a6e8205e39, topicName=肺动脉瓣置换)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Tue Feb 19 11:42:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356966, encodeId=4f2a1356966ac, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562988, encodeId=b370156298819, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576645, encodeId=3bb615e6645b8, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
    2018-10-25 zhaojie88
  5. [GetPortalCommentsPageByObjectIdResponse(id=1742529, encodeId=27e11e425295d, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Sat Mar 02 13:42:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774462, encodeId=d6e41e7446217, content=<a href='/topic/show?id=5f958205400' target=_blank style='color:#2F92EE;'>#肺动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82054, encryptionId=5f958205400, topicName=肺动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a03c38545465, createdName=cathymary, createdTime=Mon Aug 19 22:42:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808558, encodeId=4bb1180855848, content=<a href='/topic/show?id=1a6e8205e39' target=_blank style='color:#2F92EE;'>#肺动脉瓣置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82057, encryptionId=1a6e8205e39, topicName=肺动脉瓣置换)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Tue Feb 19 11:42:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356966, encodeId=4f2a1356966ac, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562988, encodeId=b370156298819, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576645, encodeId=3bb615e6645b8, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=)]
    2018-10-25 slcumt
  6. [GetPortalCommentsPageByObjectIdResponse(id=1742529, encodeId=27e11e425295d, content=<a href='/topic/show?id=39cae96626f' target=_blank style='color:#2F92EE;'>#置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79662, encryptionId=39cae96626f, topicName=置换)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a7c35056336, createdName=yxch48, createdTime=Sat Mar 02 13:42:00 CST 2019, time=2019-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774462, encodeId=d6e41e7446217, content=<a href='/topic/show?id=5f958205400' target=_blank style='color:#2F92EE;'>#肺动脉瓣#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82054, encryptionId=5f958205400, topicName=肺动脉瓣)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a03c38545465, createdName=cathymary, createdTime=Mon Aug 19 22:42:00 CST 2019, time=2019-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808558, encodeId=4bb1180855848, content=<a href='/topic/show?id=1a6e8205e39' target=_blank style='color:#2F92EE;'>#肺动脉瓣置换#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82057, encryptionId=1a6e8205e39, topicName=肺动脉瓣置换)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Tue Feb 19 11:42:00 CST 2019, time=2019-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1356966, encodeId=4f2a1356966ac, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562988, encodeId=b370156298819, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576645, encodeId=3bb615e6645b8, content=<a href='/topic/show?id=48fee966468' target=_blank style='color:#2F92EE;'>#置换术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79664, encryptionId=48fee966468, topicName=置换术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054816326830, createdName=ms117281293605716, createdTime=Thu Oct 25 04:42:00 CST 2018, time=2018-10-25, status=1, ipAttribution=)]

相关资讯

2018长城会(GW-ICC):郑杨教授:透析患者的降压目标及药物选择

高血压与肾损害密切相关,透析患者的降压目标及药物选择有其特殊性。GW-ICC 2018大会上,吉林大学第一医院郑杨教授结合相关指南及研究证据,就此话题发表精彩报告,现整理成文以飨读者。图:吉林大学第一医院 郑杨教授高血压是透析患者中的常见表现血液透析患者中高血压患病率达50%~60%以上,腹膜透析患者高血压占近30%。血压与透析患者的全因和心血管事件的关系一直存在争议,一种观点认为血压在

JACC:非心脏手术后新发房颤患者的远期血栓发生风险研究

非心脏手术术后新发房颤(POAF)患者的远期血栓栓塞发生风险尚不清楚。本研究的目的旨在比较和评估非心脏手术POAF患者和非手术性房颤患者(NVAF)的远期血栓栓塞发生风险。本研究的对象取自丹麦数据库,在1996-2015年间的所有非心脏手术患者中,有6048名(0.4%)患者发生POAF,根据年龄、性别、心衰、高血压、糖尿病、血栓栓塞史和缺血性心脏病史,纳入分析了3830名POAF患者和相应匹配的

JACC:腕管综合征患者的心脏淀粉样改变

心脏淀粉样变性患者经常会在心脏表现出现之前出现腕管综合征。本研究的目的旨在评估接受腕管手术患者心肌淀粉样沉积的发生率和类型。本研究共纳入了98名腕管综合征患者(平均年龄68岁,男性占51%),其中10名患者由组织活检染色检出淀粉样变性,2名患者被诊断为遗传性甲状腺素运载蛋白淀粉样变性(ATTR),2名患者被检查出有心脏表现,3名患者开始了治疗。在这些由活检诊断的ATTR患者中,血清的甲状腺旁素水平

JACC:血管内超声对冠心病的诊断预测价值研究

既往研究表明,血管内超声(IVUS)和射频(RF)-IVUS可以检测高风险的冠脉斑块。本研究的目的旨在评估RF-IVUS在冠心病(CAD)患者中的应用价值。本研究纳入了2008-2011年581名行冠脉造影的冠心病或稳定性心绞痛患者,并通过RF-IVUS对其一条非狭窄的冠脉进行检测评估。主要终点事件是主要心血管不良事件(MACE)。经过平均4.7年时间的随访,152名(26.2%)患者出现MACE

心机”教授被哈佛撤稿31篇的警示

美国哈佛大学医学院近日宣布,曾在该机构任职的皮耶罗·安韦萨有31篇论文因造假需要撤稿。这一消息震惊全球学术界,因为安韦萨曾被认为开创了心肌细胞再生的新领域,已经享誉10多年。他在心肌上动的“心机”终被揭穿,警示科研人员靠造假可能一时得意,但不可能永远欺骗所有人。

JAHA:芬兰研究称:从小保持理想心血管健康状况,长大后眼睛血管更漂亮

近期发表的一项芬兰研究提示,从儿童期起一直维持理想心血管健康状况的人,中年时期视网膜微血管结构更好。